Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
---|
03/07/2001 | EP0915935B1 4,7-dichlororhodamine dyes |
03/07/2001 | CN1286247A Process for preparing prolycopene and its intermediate |
03/07/2001 | CN1286245A Stable (CF3)2N(-) salt and preparing process thereof |
03/07/2001 | CN1062855C Method for preparing alkali metal salt of hydroxymethyl-iminodiacetic acid |
03/06/2001 | US6197986 Compounds containing biologically active silicon, which are under solid form |
03/06/2001 | US6197984 Method for the preparation of copolymers of ethylene/norbornene-type monomers with nickel catalysts |
03/06/2001 | US6197825 Azulenyl nitrone spin trapping agents, methods of making and using same |
03/06/2001 | US6197809 Doxorubicin antibiotic |
03/06/2001 | US6197785 Cardiovascular disorders |
03/06/2001 | US6197777 Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides |
03/06/2001 | US6197775 Viricides |
03/06/2001 | US6197766 Controlling plant insects |
03/06/2001 | US6197760 Isophosphoramide mustard analogs and use thereof |
03/06/2001 | US6197759 Osteoblast-specific mitogens and drugs containing such compounds |
03/06/2001 | US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
03/06/2001 | US6197555 Nucleotide compounds including a rigid linker |
03/06/2001 | US6197513 PNA and DNA conjugates and methods for preparation thereof |
03/06/2001 | CA1341201C Bis-(hydroxymethyl) cyclobutyl purines and pyrimidines |
03/01/2001 | WO2001014390A2 METABOTROPIC GLUTAMATE RECEPTOR LIGAND DERIVATIVES AS NAALADase INHIBITORS |
03/01/2001 | WO2001014315A1 Aminohydroxylation of olefins |
03/01/2001 | WO2001014299A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |
03/01/2001 | WO1999043314A9 Farnesyl-protein transferase inhibitors |
03/01/2001 | CA2382779A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |
03/01/2001 | CA2317284A1 Stable (cf3)2n-salts and process for preparing them |
02/28/2001 | EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient |
02/28/2001 | EP1077982A1 Method for the manufacture of n - phosphonomethylglycine from n - phosphonomethyliminodiacetic acid using a catalytic carbon |
02/28/2001 | EP1077970A1 11-aryl-benzo(b)naphtho(2,3-d)furans and 11-aryl-benzo(b)naphtho(2,3-d)thiophenes useful in the treatment of insulin resistance and hyperglycemia |
02/28/2001 | EP1077929A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
02/28/2001 | EP1077925A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
02/28/2001 | EP1027358A4 Anhydrous mononuclear tris(beta-diketonate) bismuth compositions for deposition of bismuth-containing films, and method of making the same |
02/27/2001 | US6194605 Process for preparing aluminum salts of dialkylphosphinic acids and diphosphinic acids |
02/27/2001 | US6194593 1, 2-bis(dialkylphosphino) benzene derivates having optical activites, process for producing same, and rhodium metal complexes containing same as ligands |
02/27/2001 | US6194453 Antiinflammatory agents; therapy for immunology conditions |
02/27/2001 | US6194438 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one, and compositions and methods for inhibiting abnormal cell growth comprising said derivatives |
02/27/2001 | US6194398 Phosphonate nucleotide compound |
02/27/2001 | US6194397 Enzyme inhibitors of acetylcholinesterase and butyrylcholinesterase; increased hepatoprotective and antienzyme activities; n'-substituted phosphonoalkyl-, phosphono- or thiophosphonocytisines |
02/22/2001 | WO2001012838A2 Compounds which modulate the activity of an lpa receptor |
02/22/2001 | WO2001012640A1 Method for the production of phosphonomethylglycine |
02/22/2001 | WO2001012639A1 Method for the production of phosphonomethylglycin |
02/22/2001 | WO2001012638A1 Method of purifying organic phosphoric ester |
02/22/2001 | WO2001012637A1 Transition metal complexes comprising .beta.-diiminate ligands and processes for polymerizing olefins |
02/22/2001 | WO2001012604A1 Fungicides |
02/22/2001 | WO2001012584A2 Pharmaceutical compounds |
02/22/2001 | WO2001012579A2 New stilbenes with vascular damaging activity |
02/22/2001 | WO2001012574A1 Transfer hydrogenation process |
02/22/2001 | DE19938622A1 Pure N-phosphonomethyl-glycine preparation in high yield for use as herbicide, by peroxide oxidation of N-(phosphonomethyl)-iminodiacetic acid over activated carbon catalyst having specific particle size distribution |
02/22/2001 | CA2698353A1 Pharmaceutical compounds |
02/22/2001 | CA2387651A1 Transition metal complexes comprising .beta.-diiminate ligands and processes for polymerizing olefins |
02/22/2001 | CA2383266A1 Transfer hydrogenation process |
02/22/2001 | CA2381413A1 Method for the production of phosphonomethylglycine |
02/22/2001 | CA2381412A1 Method for the production of phosphonomethylglycin |
02/22/2001 | CA2381409A1 Nitric ester derivatives |
02/22/2001 | CA2379544A1 New stilbenes with vascular damaging activity |
02/21/2001 | EP1077066A1 Preventives/remedies for skin diseases |
02/21/2001 | EP1076660A1 Substituted (4-brompyrazole-3-yl)benzazoles |
02/21/2001 | EP0874796B1 Improved metal-ligand complex catalyzed processes |
02/21/2001 | EP0809628B1 Amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups based on dicarboxylic acid diamides |
02/21/2001 | CN1284960A 'Pi' complex compounds |
02/21/2001 | CN1284897A Batch devices for reduction of compounds from biological compositions containing cells and methods of use |
02/21/2001 | CN1284896A Flow device for the reduction of compounds from biological compositions and methods of use |
02/21/2001 | CN1284508A Synthesis process of aryloxy cyclotrinitrile phosphide |
02/21/2001 | CN1284507A Process for preparation of N-alkyl-hydroxy amino-methyl-phophonic acid or its salt |
02/20/2001 | US6191298 A simple, one-step reaction process to produce the title ester by the reaction of an acetylenic compound and a phosphorothioate ester in the presence of a palladium complex catalyst; chemical intermediates |
02/20/2001 | US6191284 Ligands and complexes for enantioselective hydrogenation |
02/20/2001 | US6191276 Method for preparing sterically hindered phosphoramidates |
02/20/2001 | US6191241 Method for producing high melting-point polyolefins |
02/20/2001 | US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
02/20/2001 | US6191123 Organic-arsenic compounds |
02/20/2001 | US6191063 Polyoxyalkylated aryl phosphine-rhodium complex catalyst; efficiency/selectivity for conversion of higher molecular weight olefin starting materials |
02/20/2001 | US6190679 Storage stability; feel |
02/20/2001 | CA2084036C Use of specific counteranions to modify the solubility of tetrazolium salts |
02/20/2001 | CA2044418C Aminoalkylphosphinates and phosphinic-acid-containing polymers therefrom |
02/20/2001 | CA2022811C Phosphorus compounds |
02/15/2001 | WO2001010874A1 Process for producing 4-amino-1-hidroxybutylidene-1,1-bisphosphonic acid and its trihydrated monosodic salt |
02/15/2001 | WO2001010873A1 Novel 2-decarboxy-2-phosphinico prostaglandin f analogs |
02/15/2001 | WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
02/15/2001 | WO2000053313A3 Lanthanide catalysts for synthesis of compounds and combinatorial libraries |
02/15/2001 | WO2000052015A3 Novel phosphorus-containing prodrugs |
02/14/2001 | EP1075489A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues |
02/14/2001 | EP1075482A1 Cationic ruthenium complexes, their production and their use |
02/14/2001 | EP1075481A1 Monomeric, oligomeric and polymeric knoevenagel condensation products |
02/14/2001 | EP1075472A1 Prodrugs of benzofuranylmethyl carbamate nk 1? antagonists |
02/14/2001 | EP1021451A4 Asymmetric synthesis and catalysis with chiral heterocyclic compounds |
02/14/2001 | EP0711294B1 Use of diazapentalene derivatives as reagents specific for thiol compounds |
02/14/2001 | EP0708767B1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
02/14/2001 | CN1284072A Prodrugs of aspartyl protease inhibitors |
02/14/2001 | CN1284071A Sulphona mide derivatives as prodrugs of aspartyl protease inhibitors |
02/14/2001 | CN1284060A Novel metalloproteinase inhibitors |
02/14/2001 | CN1061982C Process for mfg. N-phosphonomethylglycine |
02/14/2001 | CN1061981C Process for preparing N-phosphonomethylamino carboxylic acids |
02/14/2001 | CN1061980C Process for preparing N-phopshonomethylamino carboxylic acids |
02/13/2001 | US6187959 Preparation of phosphonium salts |
02/13/2001 | US6187955 Guanidine derivatives and process for their production |
02/13/2001 | US6187953 A guanidinium phosphines use as catalyst ligands for the carbon-carbon linkage reactions |
02/13/2001 | US6187941 Process for the preparation of oxazaphosphorine-2-amines |
02/13/2001 | US6187922 Process for the preparation of purine derivatives |
02/13/2001 | US6187919 Ultraviolet absorbers |
02/13/2001 | US6187913 Covalently crosslinked oligonucleotides, preparation method and synthon which is of use in the method |
02/13/2001 | US6187910 Chelation compounds, radionuclide metal chelate compounds and radiolabeled targeting moieties formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic use |
02/13/2001 | US6187871 Electron acceptor compositions on polymer templates |